Download Module Description Template

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Clinical trial wikipedia , lookup

Gene therapy wikipedia , lookup

Electronic prescribing wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Pharmacy wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Transcript
Course Development Handbook
Appendix 7
s
Module specification template
Title
Code
Level
Credit rating
Pre-requisites
Type of module
Aims
Learning
outcomes/objectives
Content
Comments/notes
Parenteral Therapy
CLM04
7
20
Graduate Registered Pharmacists
The module is delivered within the workplace using the
module material provided by the London, Eastern and
South East Clinical Pharmacy Service.
1. To provide a comprehensive understanding of the
equipment involved in the administration of
parenteral solutions.
2. To critically evaluate the pharmacological and
pharmaceutical characteristics of drugs to ensure
compatability with common parenteral routes of
administration.
3. To produce clinical pharmacists competent to
advise on aspects of parenteral therapy.
4. To provide pharmacists with a comprehensive
understanding of the risks associated with
parenteral therapy and the skills required to manage
these problems.
On completion of this unit of study the participant should be
able to: 1. Describe the role of health care workers in the
prescribing, administration and monitoring of
parenteral therapy,
2. To demonstrate a critical awareness of the current
pharmacological, pharmaceutical and equipment
knowledge and to apply this to rationalise the
parenteral therapy of patients,
3. To demonstrate a comprehensive understanding of both
drug and patient parameters as they apply to the
selection of parenteral therapy.
4. To critically evaluate the patient’s response to the
technology used,
5. To demonstrate competence when providing
pharmaceutical care to patients receiving parenteral
therapy,
6. To critically evaluate the safety and effectiveness of
parenteral therapy in order to make sound judgments
when providing advice to other health care
professionals.
Describe the different methods of parenteral drug
administration, their limitations and the rationale for their
selection. Acquire a sufficient understanding of the
different types of equipment available to administer
parenteral therapy in order to be able to offer advice in
selecting a suitable device.
52
Course Development Handbook
Appendix 7
Content (cont.)
Teaching
strategies
and
Learning support
Assessment tasks
Dosage calculations relating to any drug dosing or drug
infusion administration commonly found in clinical practice
and advise nursing and medical staff on the safe practice
when mixing drugs and fluids in a bag, line or syringe.
Make recommendations on the handling, storage and
administration of parenteral drugs so that they remain safe
and efficacious for their allocated shelf life. Discuss the
provision of advice and information to healthcare staff
involved in prescribing, preparing and administering
parenteral therapy.
Identify and describe the complications associated with
parenterally administered drugs and advise on the strategies
to prevent and treat these. Understand the risk management
issues surrounding the administration of high risk drugs.
Describe the benefits and the current level of CIVA services
available.
learning Details of the standard module format are provided in the
programme specification. The material is presented in
electronic form and is normally provided to the student to
work through systematically under the supervision of an
appropriate senior clinical practitioner. Periodic meetings
with the local tutor allows understanding and the
application of this information to patient care to be
reviewed and the ability of the individual to perform key
skills to be evaluated.
Material is presented as a computer package to direct the
student learning. Students are then required to complete an
array of practice activities (see programme specification)
and demonstrate their competence to perform an array of
clinical tasks before being eligible to register for the module
assessment. Students are required to read and evaluate
articles contained within the appropriate medical journals in
addition to the appropriate chapters contained within the
general indicative texts listed below:
Dougherty L and Lamb J. Intravenous Therapy in Nursing
Practice. Churchill Livingstone 1999
Trissell LA. Handbook on Injectable Drugs.(11th Edition)
American Society of Health-System Pharmacists. 2001.
Allowed M, Stanley A & Wright P. The Cytotoxic
Handbook. 4th Edition. Radcliffe Medical Press. 2001.
The assessment strategy embraces the concept of “fitness
for purpose” so that students are required to demonstrate
their ability to apply the knowledge and skills acquired to
resolve a range of clinical problems. This requires the
student to gather and critically evaluate clinical data prior to
engaging in complex decision making, culminating in the
provision of advice to health care professionals and
patients. These problems are designed to reflect scenarios
routinely encountered in clinical practice. This requires
students to complete an objective structured clinical
examination (OSCE), comprising of 10 clinical scenarios,
reflecting clinical practice in the module being studied. To
pass the module students must satisfy the criteria in 7 of the
ten stations, and present an acceptable portfolio.
53
Course Development Handbook
Appendix 7
Brief description of module The module details the signs, symptoms and biochemical
content
and/or
aims tests associated with patients who receive parenteral
therapy.
(maximum 80 words)
A comprehensive, practice-based review of the available
information follows. Students are required to apply this
knowledge to resolve drug related problems in patients
receiving drugs via the parenteral route.
Area examination board to Course Examination Board only (normally March and
September each year)
which module relates
Produced by practitioners with a special interest in
Module team/authors/
parenteral therapy. Module leader – Jane Nichols(Associate
coordinator
Director, London, Eastern and SE Clinical Pharmacy
Services)
Semester offered, where Not applicable.
appropriate
The School of Pharmacy and Biomolecular Sciences of the
Site where delivered
university is responsible for the designing and organising
the assessment process and the overall standard of the
course. The local hospitals have responsibility for the
tuition, which is co-ordinated by the London, Eastern and
South East Clinical Pharmacy Service.
August 1994
Date of first approval
September 2004
Date of last revision
Date of approval of this
version
3
Version number
Replacement for previous
module
Field for which module is
acceptable and status in that
field
Course(s) for which module PG Certificate in Applied Therapeutics. PG Diploma in
is acceptable and status in Clinical Pharmacy Practice.
that course
Pharmacy and Biomolecular Sciences
School home
Mr Jonathan Silcock. March 2004 - 2008
External examiner
54